overview

        The Annual Conference on Precision Psychiatry, hosted by the MGH Center for Precision Psychiatry, is becoming a leading venue for showcasing advances in the application of precision medicine approaches to psychiatric research and clinical practice. Our Keynote Speakers will be Dr. Kelsey Martin, Director of the Simons Foundation Autism Research Initiative (SFARI), and Dr. Thomas Insel, former Director of NIMH and author of Healing: Our Path from Mental Illness to Mental Health (Penguin Press, 2022). The Conference will be held virtually over the course of two days: Wednesday, November 2nd and Thursday, November 3rd, 2022.

 

Join us on November 2nd & 3rd to hear from leading experts!


View Agenda

 

registration

We invite attendees to register now
to lock in our $200 rate!


Register Now

We are offering FREE registration
to students and trainees!

The Conference will be held virtually over the course of two days: Wednesday, November 2nd and Thursday, November 3rd, 2022.

 

The Conference is designed to cover a broad range of domains including:

  • Applications of AI & machine learning in psychiatry
  • Genomics and other omics
  • Precision therapeutics
  • Risk stratification for suicide and other important outcomes
  • mHealth and digital technologies
  • Implementation science
  • Ethics and equity
keynote speakers
Thomas Insel, MD
Former Director of NIMH; Author of Healing: Our Path from Mental Illness to Mental Health (Penguin Press, 2022)

Tom lnsel, M.D., a psychiatrist and neuroscientist, has been a national leader in mental health research, policy, and technology. From 2002-2015, Dr. Insel served as Director of the National Institute of Mental Health (NIMH). More recently, he led the Mental Health Team at Verily (2015-2017); co-founded Mindstrong Health (2017-2019), a start-up building tools for people with serious mental illness; and served as a special advisor to California Governor Gavin Newsom (2019), helping on behavioral health issues. In 2020, he co-founded Humanest Care, a therapeutic online community for recovery. In 2022, he joined Vanna Health as a co-founder and executive chair. Vanna Health is a start-up helping people with serious mental illness engage in psychosocial supportive care. He currently serves on the boards of Foundation for NIH, Fountain House, Schaeffer Center for Health Policy, and the Steinberg Institute (Chair, 2019-2022) as well as being an advisor to several mental health start-ups (including Alto Neuroscience, Cerebral, Compass Pathways, Owl Insights, Koa Health, Valera Health). He is the author of Healing: Our Path from Mental Illness to Mental Health (Penguin Random House, 2022). With journalist co-founders, he launched MindSite News (www.mindsitenews.org), a non-profit digital publication focused on mental health issues. Dr. Insel is a member of the National Academy of Medicine and has received numerous national and international awards including honorary degrees in the U.S. and Europe. More info at www.thomasinselmd.com.
Kelsey Martin, PhD
Director of the Simons Foundation Autism Research Initiative (SFARI), Professor of Biological Chemistry Psychiatry and Biobehavioral Sciences, UCLA

Kelsey C. Martin, M.D., Ph.D., is the Dean for the David Geffen School of Medicine at UCLA. She received her undergraduate degree in English and American Language and Literature at Harvard University. After serving as a Peace Corps volunteer in the Democratic Republic of Congo, she entered the MD-PhD program at Yale University where she studied influenza virus-host cell interactions in the laboratory of Dr. Ari Helenius, receiving her PhD degree in Molecular Biophysics and Biochemistry and her MD degree in 1992. She did her postdoctoral training in neurobiology with Dr. Eric Kandel at Columbia University, and joined the UCLA faculty in 1999. The Martin lab integrates cell biological, molecular and electrophysiological approaches to understand how experience changes brain connectivity to store memories. Their studies focus primarily on the spatial and temporal regulation of gene expression during long-lasting memory formation. Outside of UCLA, Dr. Martin is a Senior Fellow at the Howard Hughes Medical Institute Janelia Research Campus. She is on the editorial board of Cell, the board of directors for the Burroughs Wellcome Fund, the selection committee of the McKnight Scholar Awards and the board of directors for the McKnight Endowment Fund for Neuroscience. In 2016, she became a member of the American Academy of Arts and Sciences and a member of the National Academy of Medicine
 
agenda
day 1
1:00pm-1:10pm Welcome Remarks
Jordan W. Smoller, MD, ScD & Maurizio Fava, MD
1:10pm-1:40pm Conference Keynote
Thomas Insel, MD Former Director of NIMH; Author of Healing: Our Path from Mental Illness to Mental Health (Penguin Press, 2022)
1:40pm-2:00pm Moderated Discussion/Q&A
Thomas Insel, MD Former Director of NIMH; Author of Healing: Our Path from Mental Illness to Mental Health (Penguin Press, 2022)
Moderator: Jordan W. Smoller, MD, ScD

2:00pm-3:30pm

Session: Leveraging Healthcare Data for Precision Medicine
Session Chair: Collin Walsh
2:00pm-2:30pm Lea Davis, PhD Associate Professor of Medicine, Biomedical Informatic, Molecular Physiology & Biophysics, and Psychiatry & Behavioral Sciences, Vanderbilt University Medical Center
2:30pm-3:00pm Nigam Shah, PhD Professor of Medicine, Stanford University; Associate Dean and Professor of Medicine and Biomedical Data Science, Stanford University School of Medicine
3:00pm-3:30pm Moderated Discussion/Q&A
Lea Davis, PhD, Nigam Shah, PhD
Moderator: Collin Walsh, MD, MA, FAMIA
3:30pm-3:50pm BREAK

3:50pm-4:20pm

Session: Therapeutics: The Role of Academia and Industry in Advancing Precision Psychiatry
Session Chair: Jerrold Rosenbaum, MD
3:50pm-4:20pm Panel
Jenny Barnett, PhD
Chief Executive Officer, Monument Therapeutics; Chief Scientific Officer, Five Lives; Honorary Research Fellow in Dept. of Psychiatry, University of Cambridge;
David Olson, PhD Chief Innovation Officer and Head of the Scientific Advisory Board, Delix Therapeutics; Associate Professor, University of California Davis;
Morgan Sheng, PhD Core Institute Member and Co-Director of Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard
Moderator: Jerrold Rosenbaum, MD

4:20pm-5:20pm

Session: Precision Treatment Stratification and Pharmacogenetics
Session Chair: Roy Perlis, MD, MSc
4:20pm-4:50pm Chad Bousman, PhD CEO/Founder, Sequence2Script Inc.; Associate Professor, University of Calgary
4:50pm-5:20pm Katherine Scangos, MD, PhD Medical Director of Neumora
5:20pm-5:30pm Closing Remarks
Jordan W. Smoller, MD, ScD
9:00am-9:10am Welcome Remarks
Jordan W. Smoller, MD, ScD
9:10am-9:40am Conference Keynote:
Kelsey Martin, MD, PhD Director of the Simons Foundation Autism Research Initiative (SFARI), Professor of Biological Chemistry Psychiatry and Biobehavioral Sciences, UCLA
9:40am-10:00am Moderated Discussion/Q&A
Kelsey Martin, MD, PhD
Moderator: Mike Talkowski, PhD

10:00am-11:00am

Session: Methods and Tools
Session Chair: Karmel Choi, PhD
10:00am-10:30am Anthony Philippakis, MD, PhD Chief Data Officer, Broad Institute of MIT and Harvard; Venture Partner, GV
10:30am-11:00am Laura Germine, PhD Director of Brain and Cognitive Health Technology, McLean Hospital; Co-director of the Institute for Technology in Psychiatry, McLean Hospital; Assistant Professor, Harvard Medical School; President and Director, The Many Brains Project
11:00am-12:00pm Session: Precision Neuroscience & Novel Therapeutics
Session Chair: Robert Mealer, MD, PhD
11:00am-11:30am Stephen Haggarty, PhD Associate Professor of Neurology, Harvard Medical School; Associate Neuroscientist, Massachusetts General Hospital; Director of the MGH Chemical Neurobiology Laboratory at the Center for Genomic Medicine
11:30am-12:00pm Yasmin Hurd, PhD Director of the Addiction Institute, Mount Sinai; Professor, Icahn School of Medicine at Mount Sinai
12:00pm-12:20pm BREAK

12:20pm-12:50pm

Session: Data & Prediction: The Role of Academia and Industry in Advancing Precision
Psychiatry
Session Chair: Will Gordon, MD
12:20pm-12:50pm Panel
Oliver Harrison, MA, MBBS, MPH
Founder and Chief Executive Officer, Koa Health; Independent Expert Bank, Wellcome Trust; Roster of Experts- Digital Health, World Health Organization;
Scott Kollins, PhD Chief Medical Officer, Holmusk; Strategic Advisor for Digital Health Solutions, Duke Clinical Research Institute
Moderator: Will Gordon, MD

12:50pm-1:50pm

Session: Genomic Medicine
Session Chair: Laura Hercher, MA, MS
12:50pm-1:20pm Wendy Chung, MD, PhD Kennedy Family Professor of Pediatrics and Medicine, Columbia University; Precision Medicine Resource Leader, Irving Institute; Medical Director, Columbia Genetic Counseling Graduate Program; Associate Director for Education, Herbert Irving Comprehensive Cancer Center; Chief, Division of Clinical Genetics, Department of Pediatrics
1:20pm-1:50pm Jehannine Austin, PhD, MSc Professor in Dept. of Medical Genetics, University of British Columbia; Executive Director, BC Mental Health and Addictions Research Institute
1:50pm-2:20pm Moderated Discussion
Wendy Chung, MD, PhD and Jehannine Austine, PhD, MSc
Moderator: Laura Hercher, MA, MS
2:20pm-2:30pm Closing Remarks
Jordan W. Smoller, MD, ScD

Leading experts will present on a broad range of domains, tools and findings across several major areas of interest in psychiatry, including:

  • Data science and big data analytics including use of AI/ML
  • Risk stratification for suicide and other important outcomes
  • Ethical, legal and social issues
  • Genomics and other omics
  • mHealth and digital technologies
  • Biomarkers development and validation
  • Implementation science and clinical decision support
  •  Precision therapeutics
  • Learning health systems

speakers

Jehannine Austin, PhD

Director of the Simons Foundation Autism Research Initiative (SFARI), Professor of Biological Chemistry Psychiatry and Biobehavioral Sciences, UCLA

Jennifer Barnett, PhD

Chief Executive Officer, Monument Therapeutics; Chief Scientific Officer, Five Lives; Honorary Research Fellow in Dept. of Psychiatry, University of Cambridge

Chad Bousman, PhD

CEO/Founder, Sequence2Script Inc.; Associate Professor, University of Calgary

Wendy Chung, MD, PhD

Kennedy Family Professor of Pediatrics and Medicine, Columbia University; Precision Medicine Resource Leader, Irving Institute; Medical Director, Columbia Genetic Counseling Graduate Program; Associate Director for Education, Herbert Irving Comprehensive Cancer Center; Chief, Division of Clinical Genetics, Department of Pediatrics

Lea Davis, PhD

Associate Professor of Medicine, Biomedical Informatic, Molecular Physiology & Biophysics, and Psychiatry & Behavioral Sciences, Vanderbilt University Medical Center

Laura Germine, PhD

Director of Brain and Cognitive Health Technology, McLean Hospital; Co-director of the Institute for Technology in Psychiatry, McLean Hospital; Assistant Professor, Harvard Medical School; President and Director, The Many Brains Project

Stephen Haggarty, PhD

Associate Professor of Neurology, Harvard Medical School; Associate Neuroscientist, Massachusetts General Hospital; Director of the MGH Chemical Neurobiology Laboratory at the Center for Genomic Medicine

Oliver Harrison, MA, MBBS, MPH

Founder and Chief Executive Officer, Koa Health; Independent Expert Bank, Wellcome Trust; Roster of Experts- Digital Health, World Health Organization

Yasmin Hurd, PhD

Director of the Addiction Institute, Mount Sinai; Professor, Icahn School of Medicine at Mount Sinai

Scott Kollins, PhD

Chief Medical Officer, Holmusk; Strategic Advisor for Digital Health Solutions, Duke Clinical Research Institute

David Olson, PhD

Chief Innovation Officer and Head of the Scientific Advisory Board, Delix Therapeutics; Associate Professor, University of California Davis

Anthony Philippakis, MD, PhD

Chief Data Officer, Broad Institute of MIT and Harvard; Venture Partner, GV

Nigam Shah, PhD

Professor of Medicine, Stanford University; Associate Dean and Professor of Medicine and Biomedical Data Science, Stanford University School of Medicine

Morgan Sheng, PhD

Core Institute Member and Co-Director of Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard

Katherine Scangos, MD, PhD

Medical Director, Neumora ; Co-Director TMS and Neuromodulation Program, University of California San Francisco

sponsorship

We are excited to offer the opportunity to partner with Massachusetts General Hospital’s Center for Precision Psychiatry to support our second annual Conference on Precision Psychiatry.This two-day conference will feature insight from Massachusetts General Hospital faculty and esteemed experts, showcasing advances in the application of precision medicine.

For more information about sponsoring this program contact the Center for Precision Psychiatry through the form below or send us an email at mghctrprecisionpsych@mgh.harvard.edu

 

Fill out this form to connect with us about sponsorship opportunities!

Name

Program Committee Members:

Megan Candito
Karmel Choi, PhD

Maurizio Fava, MD
Roy Perlis, MD

Robbie Mealer, MD, PhD
Andy Nierenberg, MD
Jerrold Rosenbaum, MD
Ashley Seiger
Jordan Smoller, MD, ScD
Sabine Wilhelm, PhD